Gland Pharma Ltd News
Stocks to Watch today, Nov 4: Bharti Airtel, Titan, Hero MotoCorp, Cipla
Stocks to Watch today, November 4, 2025: From Bharti Airtel, Hero MotoCorp, Titan Company, and Power Grid, here is a list of stocks that will be in focus today
 "Stocks to Watch today, Nov 4: Bharti Airtel, Titan, Hero MotoCorp, Cipla")
Gland Pharma Q2 results: Profit rises 12% on recovery at Europe's Cenexi
The consolidated net profit rose to 1.84 billion rupees (nearly $21 million) for the quarter ended September 30 from 1.64 billion rupees a year earlier
 "Gland Pharma Q2 results: Profit rises 12% on recovery at Europe's Cenexi")
Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's
Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators; check more details
 "Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's")
Gland Pharma shares jump 6% post Q1 show; should you buy, sell or hold?
The pharma company's profit after tax (PAT) for the quarter ended June 30, 2025, stood at ₹215 crore, up 50 per cent from ₹143 crore reported in the corresponding quarter of the previous fiscal year.
 "Gland Pharma shares jump 6% post Q1 show; should you buy, sell or hold?")
Nifty Pharma down 1.5%: Granules, Biocon lead with over 2% fall; Here's why
Pharma stocks fell after Trump said tariffs will be imposed within a week, rising up to 250 per cent in 12-18 months
 "Nifty Pharma down 1.5%: Granules, Biocon lead with over 2% fall; Here's why")
Gland Pharma Q1 profit jumps 50% on core growth, Cenexi turnaround
Sequentially, the company's net profit rose by 15 per cent, and revenue increased by 6 per cent
 "Gland Pharma Q1 profit jumps 50% on core growth, Cenexi turnaround")
Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?
The daily RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.
 "Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?")
Gland Pharma shares rise on GMP nod for Telangana manufacturing unit
Gland Pharma shares rose 2 per cent after it received a GMP certification from the Danish Medicines Agency for its Telangana plant
Glenmark, Laurus Lab: Will Trump's 200% tariff threat derail pharma stocks?
Donald Trump threatens of a potential 200% tariff on pharma imports; can this derail the rally in pharma shares, which have gained up to 50% in 3 months. Here's what the technical charts suggest.
 "Glenmark, Laurus Lab: Will Trump's 200% tariff threat derail pharma stocks?")
